BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chevaliez S, Asselah T. Mechanisms of non-response to antiviral treatment in chronic hepatitis C. Clin Res Hepatol Gastroenterol. 2011;35 Suppl 1:S31-S41. [PMID: 21742299 DOI: 10.1016/s2210-7401(11)70005-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Salvatierra K, Fareleski S, Forcada A, López-Labrador FX. Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective. World J Virol 2013; 2(1): 6-15 [PMID: 24175225 DOI: 10.5501/wjv.v2.i1.6] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
2 Campo DS, Skums P, Dimitrova Z, Vaughan G, Forbi JC, Teo CG, Khudyakov Y, Lau DT. Drug resistance of a viral population and its individual intrahost variants during the first 48 hours of therapy. Clin Pharmacol Ther 2014;95:627-35. [PMID: 24488144 DOI: 10.1038/clpt.2014.20] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 Khan HU, Khan S, Shah MA, Attaullah S, Malik MA. Pre-existing resistance associated polymorphisms to NS3 protease inhibitors in treatment naïve HCV positive Pakistani patients. PLoS One 2020;15:e0231480. [PMID: 32275694 DOI: 10.1371/journal.pone.0231480] [Reference Citation Analysis]
4 Friborg J, Ross-Macdonald P, Cao J, Willard R, Lin B, Eggers B, McPhee F. Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes. PLoS One. 2015;10:e0121734. [PMID: 25826356 DOI: 10.1371/journal.pone.0121734] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mori N, Nakasone K, Tomimori K, Ishikawa C. Beneficial effects of fucoidan in patients with chronic hepatitis C virus infection. World J Gastroenterol 2012; 18(18): 2225-2230 [PMID: 22611316 DOI: 10.3748/wjg.v18.i18.2225] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
6 Dinu S, Țârdei G, Ceaușu E, Florescu SA, Micu L, Ecobici AM, Mihăilă M, Oprișan G. Detection of anti-protease inhibitors resistance mutations in HCV strains infecting treatment-naïve chronic patients from Romania. Revista Romana de Medicina de Laborator 2018;26:443-9. [DOI: 10.2478/rrlm-2018-0029] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]